Ischemic stroke
Conditions
Interventions
experimental group:standard therapies based on guideline and NBP
control group:standard therapies based on guideline
Sponsors
Deyang People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Symptoms of neurological deficit caused by ischemic stroke; 2. Age from 18 years to 80 years; 3. Patients with a National Institutes of Health Stroke Scale (NIHSS) score from 1 to 10 points; 4. From the onset of stroke symptoms to the intended treatment <= 48 hours;(for wakeup stroke patients, define the onset time as when the patient starts to fall asleep); 5. The symtoms lasts for at least 30 minutes without significant improvement or deterioration before treatment; 6. Patients who provided consent to participate in this study.
Exclusion criteria
Exclusion criteria: 1. Patients with a Modified Rankin Scale (MRS) score >= 2 points before stroke; 2. Transient ischemic attack (TIA); 3. Patients receiving endovascular thrombectomy; 4. Patients with severe liver and kidney dysfunction, cardiac dysfunction, peripheral blood disease, or other severe systemic diseases, etc.; 5. Intracranial hemorrhagic diseases seen on CT / MRI: cerebral hemorrhage, subarachnoid hemorrhage, etc., or diseases with a bleeding tendency; 6. Patients with concurrent malignant tumors or undergoing anti-tumor treatment; 7. People with a history of allergies to celery or NBI; 8. Patients who are pregnant, breastfeeding, or have a chance of becoming pregnant, and who plan to become pregnant; 9. Participated in other interventional clinical studies within 3 months or is participating in other interventional clinical studies; 10. Blood glucose level 22.2 mmol / L; 11. Patients that the investigator considers inappropriate for this clinical study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| END; | — |
Countries
China
Contacts
Public ContactLi Jie
Deyang People's Hospital
Outcome results
None listed